ZeePedia

Basic Neurochemistry:ACH and Behaviors, Arousal, Drinking, Sham rage and attack

<< Basic Neurochemistry:5HT and Behaviors, Serotonin and sleep, Other behaviours
Brain and Motivational States:Homeostasis, Temperature Regulation, Ectotherms >>
img
Neurological Basis of Behavior (PSY - 610)
VU
Lesson36
Basic Neurochemistry
Objectives:
To familiarize the students with the
Various NT and their role in the modulation of behaviors
Classification  of  Neurotransmitters.  Monoamines:  Catechoalimnes
and
Indolemaine,
acetylcholine, amino acid, and Peptide
Neurotransmitters role in modulation of behaviors and Aberration
Drugs and Behavior:
Classification of Psychopharmacological substances
Behavioral correlates, Treatment:
Mechanism of synaptic transmission
Major Neurotransmitter: Acetylcholine (continued)
ACH and Behaviors.
As we have discussed in the last lesson, Ach has a unique and important neurotransmitter role in the
brain. Without the normal levels of Ach and its receptors working effectively the brain would not be
able to command the muscles of the body.
1. Arousal: Ach has an important role as excitant of neural activity. This means that brain
electrical activity is aroused and can be monitored by the Electtroencepaholographic (EEG)
recordings. When ACH is injected intravenously or applied to cortex it leads to increased EEG
activity. Further, when anticholinergics are administered as they block and reduce Ach levels in
the brain, the EEG arousal is also blocked. Interestingly, this does not affect the behavioral
arousal). Ach is involved in sleeping and awakening via the locus coerreleus, which may
explain the involvement of Ach in brain electrical activity arousal.
2.
Drinking: Ach is important in drinking and fluid regulation. The regulation of the water intake
takes place via the Ach mechanism. The cellular dehydration is mediated by the cholinoceptive
system of neurons in the preoptic area of the hypothalamus. They monitor the extracellular
space for volumetric changes (changes in the volume of fluid) produced after changes in
isotonic body fluids. (Whenever the intracellular membrane runs short of fluid it takes in fluids
from the extracellular membrane, as the survival of cell is more important!).This leads to the
release of Renin from kidneys which lead to increased formation of Angiotensin which then
stimulates the neurons in the preoptic area. Thus, this communication goes from the brain to the
kidneys and back leading to an increase in fluid and salt intake. The messages begin with the
Cholinoceptive receptors sending out the signals.
3. Sham rage and attack: Sham rage is the physical appearance of rage without an object of rage
in front of the animal (cats and rats). In cats rage appears in hissing and spitting, and raised hair
on the dorsal surface of the body and the tail. Sham rage is induced in cats and rats by the
cholinergic stimulation of amygdala and septum. Aggression is also produced by midbrain
ventral tegmental area. Further, the killing attack pathways in rat (of mice) and cat (of rats) are
cholinergically organized. The cholinergic stimulation of amygdala, LH, midbrain tegmental
regions leads to a quiet biting attack in rat and cats. How do we know? This attack is blocked by
atropine
4.
Punishment: Reinforcing stimuli increases the probability of a response to it whereas
punishing stimuli decreases the probability of a response to it. The intracranial self stimulation
138
img
Neurological Basis of Behavior (PSY - 610)
VU
is part of the reward systems and reinforcing so an animal would keep self stimulating for its
own reward. On the other hand, the periventricular area in hypothalamus part of punishment
systems. The ventromedial hypothalamus is part of this punishment system. Rats previously
trained for Variable Interval Schedule (VIS) for food are run in an experiment where every
response is followed by a shock. (Remember VIS is when the time between reinforcement
varies!). When every response is followed by a shock, a reduction in VIS response follows. If
we lesion the Ventromedial nuclei (VMN), it leads to increase in the response which had been
depressed (leads to disinhibition). Anti Ach also does the same, which is they lead to an
increase in disinhibition of the punished response. Inhibition of punished response means the
animal would stop responding, but disinhibition means that the response would return as the
inhibitor has been blocked. AntiAch are involved in removing the inhibition.
5. Alzheimers: Alzheimer's is a disease of old age where degeneration of brain takes place to a
point where the person cannot carry out any function. The important feature of this disease is
loss of memory. Recently muscarinic receptor agonists have been used in the treatment of
Alzheimer's disease. This replaces depleted Ach in the basal forebrain as the neurons in this area
degenerate. Another treatment of Alzheimer's patients is administration of acetylcholinesterase
inhibitors this increases levels of ACH in the synapse as the breakdown is blocked), thereby
increasing cholinergic activity in damaged brain areas. Physostigminewas used earlier but
results indicated strong side effects. Tetrahydroaminoacridine (THA, or tacrine), first
cholinesterase inhibitor which has been approved for Alzheimer's patients. Patients given THA
shown some reduction of Alzheimer's symptoms were able to resume normal activity.
However, not all patients can use it as it has strong side effects on increasing liver enzymes.
Ach is also involved in learning, memory, motor behaviors (it works in balance with DA for
Parkinson's and other motor disorders), in pain, in coordination with brain opioids.
Other NT's
In addition to the neurotansmitters, we have discussed so far, the Catecholamines, the Indolamine,
and Acetylcholine; there are other neurotransmitters which are active within the CNS. We will
discuss them in brief.
1. Glutamic acid: Glutamate and GABA are found in simple organisms. The first neurotransmitter
to be evolved in the brain is Glutamate. Glutamate is an excitatory neurotransmitter, its receptors
found all over the brain. Chinese food contains a large amount of Monosodium Glutamate. There
are three types of receptors: NMDA, quisquilate and the kainite receptors. The receptors are all
important in working with other NTs
2. GABA. Gamma Amino butyric acid was first synthesized in 1883 known to be a metabolite of
plant and microbial metabolism. It was discovered in the mammalian brain in the 1950's, and in
very high concentrations in the brain and the spinal cord. In the brain GABA is found in amounts
10-15 times greater than DA, NE or 5HT also a minuscule amount found in the retina. Even till now
it is not very extensively studied. It is generally classified as an inhibitory NT and accounts along
with other amino acids for a major part of the neuronal transmission. GABA works to balance the
monoamines DA, NA and 5HT wherever they are involved. GABA is implicated directly in
Huntington's chorea which is due to degeneration of GAB Aminergic neurons. GABA is indirectly
involved in Parkinson's, Epilepsy (abnormality in the biochemistry of GAB Aminergic neurons)
and Schizophrenia
GABA Synthesis; This involves only two steps: one to synthesize it and one to break it down:
1. One step synthesis from its amino acid precursor Glutamic Acid which is decarboxylased by the
enzyme Glutamic acid decarboxyalse.
139
img
Neurological Basis of Behavior (PSY - 610)
VU
Glutamic acid--------------------GABA
Glutamic acid decarboxylase (GAD) and coenzyme pyroxidal phosphate, this process can be
blocked by ions such as chloride and zinc.
2. Catabolism: GABA--is trans-aminated by GABA-A-oxoglutarate transaminase. GABA is
transformed into Succinic Acid Semialdehyde to return back into the Krebs cycle
In the transaminase process- GABA conversion is reversed to Glutamic acid through alpha
ketoglutarate which acts as amine acceptor.
Distribution and pharmacological agents
From monkey to human brain 1968-1971 studies showed the highest GABAminergic concentrations
in the Substantia Nigra (SN) Globus Pallidus (GP), and the Hypothalamus (hyp)
Agonists: The post receptor GABA agonist is muscimol. This leads to increased arousal, self
mutilation, increased feeding if placed in the hypothalamus (disinhibition of inhibition)
Antagonists: Post receptor antagonist or receptor blockade by picrotoxin and bicuculine.
Benzodiazepines (Valium and Librium) stimulate a particular site of GABA Aminergic neurons.
This alleviates the anxiety symptoms/response.
Glycine: is another Inhibitory neurotransmitter like GABA however research is still ongoing to
identify its role. It is found in the mammalian spinal cord and the brain. It is found in greater
amounts in the spinal grey matter than the brain. Suggesting it may be working with the interneuron.
However, no distinct and clear glycine pathways in the brain
Strychnine (poison) blocks the action of glycine and also blocks postsynaptic inhibition.
PEPTIDES: neuroactive peptides are candidates for neurotransmitters. Some of these are like
orthodox NT's, some are performing modulatory or regulatory roles, and that these also act as
neurohormones.
BRAIN OPIOIDS, ANGIOTENSIN II, (thirst) Oxytocin and Vasopressin, Leutenizing Hormone
Releasing Hormones (LH-RH), Substance P and Adreno-Corticotropic Hormone (ACTH)
Brain Opioids: Endorphins (large molecules) and Enkephalins (smaller molecules):
Hughes and Kosterlitz (1975) in Aberdeeen discovered the existence of brain opioids in the brain.
This was a landmark finding because for the first time it was found that this chemical compound
was similar in composition to the opiates morphine, heroin etc. In later researches, Huda Akil and
her research group reported that the highest concentration in Substantia Nigra, lateral hypothalamus,
cerebral Cortex, Periaquaductal gray.
Extracts taken out from the brain, when administered to laboratory animals led to analgesia, wet dog
shakes upon application (in a manner similar to administration of opiates).Similarly, akinesia,
hypothermia, rigidity, catalepsy were also seen.
The question is whether brain opioids are natural neuroleptics or not (neuroleptics are antipsychotic
drugs).
140
img
Neurological Basis of Behavior (PSY - 610)
VU
In some cases psychotic patients who are not responding to other treatment drugs (neuroleptics)
have responded short term endorphin treatment (Mcgreer and Mcgreer 1980).
These are also involved in emotions, growth, pleasure (acting through the mesolimbic DA
pathways), stress induced analgesia (Akil et al 1975), growth and development (Najam and
Panksepp 1980).
Opioid antagonists have also been found effective in treatment of autism and childhood disorder (
Panksepp et al's theory of brain opioids and attachment states that brain opiates are natural
conforters in the brain, it is when they are blocked that the addicts turn to morphine/heroin, and
autistic children have higher than normal brain opiate level therefore). The discovery that pain and
acupuncture pathways are similar to brain opioids pathways in the body and spinal cord provide
strong evidence for the involvement of brain opiates in the pain and acupuncture. Narcotic
analgesics such as morphine heroin are severely addictive and have a high tolerance value are potent
analgesiscs, potent anti congestion, and also for stomach and digestive problems. The interesting
aspect of opiates effect on pain is that it is only the affective component which is reduced (one does
not feel the pain) the physical component is still there. Pain is still there but the patients do not care
about it, the reaction to pain is diminished.
Psychotogenic compounds
Hallucinogens:
1. LSD is a potent drug in fact so potent that a small dose of 1/10,000 gram is effective. This has
great tolerance to the point that the same dose is not effective if taken 2nd time which means an
increased dosage needed every time for an effect to take place. The LSD "trip" depends on the
mood and personality of the user and can be controlled
2. Mescaline also hallucinogenic compound made from plants extracts in Mexico. It is used in
religious ceremonies by tribes in Mexico
Psychopharmacology
This area of specialization is the study of the effects of drugs on psychological processes. It is both a
basic and an applied science. " A recognition of the interrelationships between pharmacological
agents, neuro regulators, and behavior has become essential for those involved in helping
individuals who have psychiatric disorders" Therefore in order to develop drugs research in the
laboratory is needed before the drugs can be tested and used- especially on humans.
The evidence is provided when the symptoms of a psychiatric disorder are removed linked to
neurotransmitter, and then the normalization of behavior should occur with normalization of levels of
NT in the brain. Further, known effective exogenous substances should have similar chemical effects
as the endogenous (brain) chemicals. Pharmacological substances should be able to interact with NTs
at a given sites if they have the same chemical composition.
References
1. Kalat J.W (1998) Biological Psychology Brooks/ Cole Publishing
2. Carlson N.R. (2005) Foundations of Physiological Psychology Allyn and Bacon, Boston
3. Pinel, John P.J. (2003) Biopsychology (5th edition) Allyn and Bacon Singapore
4 Bloom details later
5. Bridgeman,B (1988)The Biology of Behavior and Mind. John Wiley and Sons New York
6. Seigel,G.J. ( Ed. in chief) Agranoff, B.W, Albers W.R. and Molinoff, P.B. (Eds.) Basic
Neurochemistry: Molecular, Cellular and Medical Aspects
141
img
Neurological Basis of Behavior (PSY - 610)
VU
7. Cooper, J.R... Bloom, F.E and Roth H.R. (1978): The Biochemical basis of Neuropharmacology (3rd
Edition), Oxford University Press, UK
142
Table of Contents:
  1. INTRODUCTION:Descriptive, Experimental and/ or Natural Studies
  2. BRIEF HISTORICAL REVIEW:Roots of Behavioural Neurosciences
  3. SUB-SPECIALIZATIONS WITHIN THE BEHAVIORAL NEUROSCIENCES
  4. RESEARCH IN BEHAVIOURAL NEUROSCIENCES:Animal Subjects, Experimental Method
  5. EVOLUTIONARY AND GENETIC BASIS OF BEHAVIOUR:Species specific
  6. EVOLUTIONARY AND GENETIC BASIS OF BEHAVIOUR:Decent With Modification
  7. EVOLUTIONARY AND GENETIC BASIS OF BEHAVIOUR:Stereoscopic vision
  8. GENES AND EXPERIENCE:Fixed Pattern, Proteins, Genotype, Phenotypic
  9. GENES AND EXPERIENCE:Mendelian Genetics, DNA, Sex Influenced Traits
  10. GENES AND EXPERIENCE:Genetic Basis of behavior, In breeding
  11. GENES AND EXPERIENCE:Hybrid vigor, Chromosomal Abnormalities
  12. GENES AND EXPERIENCE:Behavioral Characteristics, Alcoholism
  13. RESEARCH METHODS AND TECHNIQUES OF ASSESSMENT OF BRAIN FUNCTION
  14. RESEARCH METHODS AND TECHNIQUES OF ASSESSMENT OF BRAIN FUNCTION:Activating brain
  15. RESEARCH METHODS AND TECHNIQUES OF ASSESSMENT OF BRAIN FUNCTION:Macro electrodes
  16. RESEARCH METHODS AND TECHNIQUES OF ASSESSMENT OF BRAIN FUNCTION:Water Mazes.
  17. DEVELOPMENT OF THE NERVOUS SYSTEM:Operation Head Start
  18. DEVELOPMENT OF THE NERVOUS SYSTEM:Teratology studies, Aristotle
  19. DEVELOPMENT OF THE NERVOUS SYSTEM:Stages of development, Neurulation
  20. DEVELOPMENT OF THE NERVOUS SYSTEM:Cell competition, Synaptic Rearrangement
  21. DEVELOPMENT OF THE NERVOUS SYSTEM:The issues still remain
  22. DEVELOPMENT OF THE NERVOUS SYSTEM:Post natal
  23. DEVELOPMENT OF THE NERVOUS SYSTEM:Oxygen level
  24. Basic Neuroanatomy:Brain and spinal cord, Glial cells, Oligodendrocytes
  25. Basic Neuroanatomy:Neuron Structure, Cell Soma, Cytoplasm, Nucleolus
  26. Basic Neuroanatomy:Control of molecules, Electrical charges, Proximal-distal
  27. Basic Neuroanatomy:Telencephalon, Mesencephalon. Myelencephalon
  28. Basic Neuroanatomy:Tegmentum, Substantia Nigra, MID BRAIN areas
  29. Basic Neuroanatomy:Diencephalon, Hypothalmus, Telencephalon, Frontal Lobe
  30. Basic Neurochemistry:Neurochemicals, Neuromodulator, Synaptic cleft
  31. Basic Neurochemistry:Changes in ionic gates, The direct method, Methods of Locating NT
  32. Basic Neurochemistry:Major Neurotransmitters, Mesolimbic, Metabolic degradation
  33. Basic Neurochemistry:Norepinephrine/ Noradrenaline, NA synthesis, Noadrenergic Pathways
  34. Basic Neurochemistry:NA and Feeding, NE and self stimulation: ICS
  35. Basic Neurochemistry:5HT and Behaviors, Serotonin and sleep, Other behaviours
  36. Basic Neurochemistry:ACH and Behaviors, Arousal, Drinking, Sham rage and attack
  37. Brain and Motivational States:Homeostasis, Temperature Regulation, Ectotherms
  38. Brain and Motivational States:Biological Rhythms, Circadian rhythms, Hunger/Feeding
  39. Brain and Motivational States:Gastric factors, Lipostatic theory, Neural Control of feeding
  40. Brain and Motivational States:Resting metabolic state, Individual differences
  41. Brain and Motivational States:Sleep and Dreams, Characteristics of sleep
  42. Higher Order Brain functions:Brain correlates, Language, Speech Comprehension
  43. Higher Order Brain functions:Aphasia and Dyslexia, Aphasias related to speech
  44. Higher Order Brain Functions:Principle of Mass Action, Long-term memory
  45. Higher Order Brain Functions:Brain correlates, Handedness, Frontal lobe